Mortality after cerebral angiography with or without radioactive thorotrast: An international cohort of 3,143 two-year survivors

Radiation Research

Volumn 156, Issue 2, 2001, Pages 136-150

  Travis, L B ^a   Land, C E ^a   Andersson, M ^a   Nyberg, U ^a   Goldman, M B ^a   Gaul, L K ^a   Berger, E ^a   Storm, H H ^a   Hall, P ^a   Auvinen, A ^a   Janower, M L ^a   Holm, L E ^a   Monson, R R ^a   Schottenfeld, D ^a   Boice J D , Jr ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THORIUM DIOXIDE;

ADULT; AGED; ALPHA RADIATION; ARTICLE; BRAIN ANGIOGRAPHY; CAUSE OF DEATH; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RESPIRATORY TRACT DISEASE;

TRIXIS;

EID: 0034918488     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)156[0136:MACAWO]2.0.CO;2     Document Type: Article

References (52)

1. History of the use and toxicity of Thorotrast
2. Cancer risk following exposure to Thorotrast: Overview in relation to a case report
3. Clinical consequences of Thorotrast in a long-term survivor
4. Abdominal pain: Do not forget Thorotrast
5. Identification of Thorotrast in damaged kidney 50 years after ureteropyelography
6. Thorotrast-associated oropharyngeal hemorrhage: Treatment by means of carotid occlusion with use of flow arrest and fibered coils
7. Cervical Thorotrast granuloma: A review of the literature and a new treatment modality
8. Late effects of Thorotrast in cerebral angiography
9. Effects of long-term Thorotrast exposure
10. Malignancies in Danish Thorotrast patients
11. Mortality and cancer incidence after cerebral arteriography with or without Thorotrast
12. Mortality after long-term exposure to radioactive Thorotrast: A forty-year follow-up survey in Sweden
13. Epicure Users Guide
14. Nonparametric estimation from incomplete observations
15. Epidemiological results and dosimetric calculations - An update of the German Thorotrast study
16. The German Thorotrast study: Recent results and assessment of risks
17. Mortality in the Portuguese Thorotrast study
18. Summary of entire Japanese Thorotrast follow-up study: Updated 1998
19. Epidemiological, pathological and dosimetric status of Japanese Thorotrast patients
20. Biokinetic models and data
21. Tissue dose in Thorotrast patients
22. Pattern of mortality among Danish Thorotrast patients
23. Noncancer disease incidence in the atomic bomb survivors: 1958-1986
24. Late effects of Thorotrast on the liver and spleen and their efferent lymph nodes
25. The reticuloendothelial system and macrophage-monocyte system in Thorotrast patients
26. The distribution of Thorotrast in human bone marrow: A case report
27. Leukemia and other related hematological disorders among Danish patients exposed to Thorotrast
28. Long-term effects of internally deposited alpha-particle emitting radionuclides
29. Cumulative genetic damage in hematopoietic stem cells in a patient with a 40-year exposure to alpha particles emitted by thorium dioxide
30. Chromosomal aberrations and hprt mutant frequencies in long-term American Thorotrast survivors
31. Alpha-particle-induced chromosomal instability in human bone marrow cells
32. 220Rn detector used to assess Thorotrast exposure
33. Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury
34. Systemic deposits of thorium in Thorotrast patients with particular reference to sites of minor storage
35. Chronic diffuse interstitial fibrosis of the lung in uranium miners
36. Lung cancer in a Thorotrast administered patient
37. Lung fibrosis induced by Thorotrast
38. Malignancies in Portuguese Thorotrast patients
39. Primary liver tumors among Danish patients exposed to Thorotrast
40. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors
41. Cancer incidence among Danish Thorotrast-exposed patients
42. Prospective epidemiological study of Thorotrast-exposed patients in Portugal
43. Development of hepatic angiosarcoma in man induced by vinyl chloride, Thorotrast and arsenic. Comparison with cases of unknown etiology
44. Hepatic angio-sarcoma associated with androgenic-anabolic steroids
45. p53 mutations in tumor and non-tumor tissues of Thorotrast recipients: A model for cellular selection during radiation carcinogenesis in the liver
46. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2
47. The excretion of thorium and thorium daughters after Thorotrast administration
48. Fatal abdominal Thorotrast granuloma